| Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis WJ Jansen, R Ossenkoppele, DL Knol, BM Tijms, P Scheltens, ... Jama 313 (19), 1924-1938, 2015 | 1175 | 2015 |
| Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis R Ossenkoppele, WJ Jansen, GD Rabinovici, DL Knol, WM van der Flier, ... Jama 313 (19), 1939-1950, 2015 | 504 | 2015 |
| Automated volumetry and regional thickness analysis of hippocampal subfields and medial temporal cortical structures in mild cognitive impairment PA Yushkevich, JB Pluta, H Wang, L Xie, SL Ding, EC Gertje, L Mancuso, ... Human brain mapping 36 (1), 258-287, 2015 | 422 | 2015 |
| Amyloid imaging in mild cognitive impairment subtypes DA Wolk, JC Price, JA Saxton, BE Snitz, JA James, OL Lopez, ... Annals of Neurology: Official Journal of the American Neurological …, 2009 | 362 | 2009 |
| Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease OL Lopez, JT Becker, AS Wahed, J Saxton, RA Sweet, DA Wolk, W Klunk, ... Journal of Neurology, Neurosurgery & Psychiatry 80 (6), 600-607, 2009 | 336 | 2009 |
| Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging DR Roalf, PJ Moberg, SX Xie, DA Wolk, ST Moelter, SE Arnold Alzheimer's & Dementia 9 (5), 529-537, 2013 | 334 | 2013 |
| Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated JL Robinson, EB Lee, SX Xie, L Rennert, ER Suh, C Bredenberg, ... Brain 141 (7), 2181-2193, 2018 | 309 | 2018 |
| Detection of cortical thickness correlates of cognitive performance: reliability across MRI scan sessions, scanners, and field strengths BC Dickerson, E Fenstermacher, DH Salat, DA Wolk, RP Maguire, ... Neuroimage 39 (1), 10-18, 2008 | 300 | 2008 |
| Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease Y Chen, DA Wolk, JS Reddin, M Korczykowski, PM Martinez, ES Musiek, ... Neurology 77 (22), 1977-1985, 2011 | 279 | 2011 |
| Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias M Yarchoan, SX Xie, MA Kling, JB Toledo, DA Wolk, EB Lee, ... Brain 135 (12), 3749-3756, 2012 | 275 | 2012 |
| Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional–executive network function in Alzheimer’s disease DA Wolk, BC Dickerson, Alzheimer’s Disease Neuroimaging Initiative, ... Proceedings of the National Academy of Sciences 107 (22), 10256-10261, 2010 | 242 | 2010 |
| Basal cerebral metabolism may modulate the cognitive effects of Aβ in mild cognitive impairment: an example of brain reserve AD Cohen, JC Price, LA Weissfeld, J James, BL Rosario, W Bi, RD Nebes, ... Journal of Neuroscience 29 (47), 14770-14778, 2009 | 237 | 2009 |
| Neurodegeneration across stages of cognitive decline in Parkinson disease D Weintraub, J Doshi, D Koka, C Davatzikos, AD Siderowf, JE Duda, ... Archives of neurology 68 (12), 1562-1568, 2011 | 234 | 2011 |
| A phase II study of fornix deep brain stimulation in mild Alzheimer’s disease AM Lozano, L Fosdick, MM Chakravarty, JM Leoutsakos, C Munro, E Oh, ... Journal of Alzheimer's Disease 54 (2), 777-787, 2016 | 232 | 2016 |
| The effects of aging and Alzheimer's disease on cerebral cortical anatomy: specificity and differential relationships with cognition A Bakkour, JC Morris, DA Wolk, BC Dickerson Neuroimage 76, 332-344, 2013 | 225 | 2013 |
| MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults BC Dickerson, DA Wolk Neurology 78 (2), 84-90, 2012 | 219 | 2012 |
| Effects of the insulin sensitizer metformin in Alzheimer’s disease: Pilot data from a randomized placebo-controlled crossover study AM Koenig, D Mechanic-Hamilton, SX Xie, MF Combs, AR Cappola, L Xie, ... Alzheimer disease and associated disorders 31 (2), 107, 2017 | 203 | 2017 |
| Fractionating verbal episodic memory in Alzheimer's disease DA Wolk, BC Dickerson, Alzheimer's Disease Neuroimaging Initiative Neuroimage 54 (2), 1530-1539, 2011 | 192 | 2011 |
| Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease D Weintraub, N Dietz, JE Duda, DA Wolk, J Doshi, SX Xie, C Davatzikos, ... Brain 135 (1), 170-180, 2012 | 177 | 2012 |
| Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease ES Musiek, Y Chen, M Korczykowski, B Saboury, PM Martinez, JS Reddin, ... Alzheimer's & Dementia 8 (1), 51-59, 2012 | 171 | 2012 |
Sandhitsu DasResearch Assistant Professor, University of PennsylvaniaDirección de correo verificada de seas.upenn.edu
